电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Annexin IV 抗体 (AA 1-321) (APC)

This anti-Annexin IV antibody is a 兔 多克隆 antibody detecting Annexin IV in IHC, ICC, FACS 和 IF. Suitable for 人.
产品编号 ABIN5564829
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for Annexin IV 抗体 (AA 1-321) (APC) (ABIN5564829)

抗原

See all Annexin IV (ANXA4) 抗体
Annexin IV (ANXA4) (Annexin A4 (ANXA4))

适用

  • 84
  • 33
  • 33
  • 20
  • 15
  • 4
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1

宿主

  • 112
  • 25
  • 1

克隆类型

  • 94
  • 42
多克隆

标记

  • 77
  • 25
  • 9
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
This Annexin IV antibody is conjugated to APC

应用范围

  • 104
  • 54
  • 41
  • 30
  • 25
  • 25
  • 20
  • 10
  • 7
  • 6
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (IHC), Immunocytochemistry (ICC), Flow Cytometry (FACS), Immunofluorescence (IF)
  • 抗原表位

    • 11
    • 9
    • 7
    • 5
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-321

    产品特性

    Purified antibody validated for specificity and sensitivity.

    纯化方法

    Affinity Purified

    免疫原

    Human Annexin A4 (1-321 aa) expressed in E. coli.
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    限制

    仅限研究用
  • 状态

    Lyophilized

    缓冲液

    Lyophilized from PBS pH 7.4, 20 mg/mL BSA, and 0.02 % Sodium Azide

    储存液

    Sodium azide

    注意事项

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
  • 抗原

    Annexin IV (ANXA4) (Annexin A4 (ANXA4))

    基因ID

    307

    UniProt

    P09525
You are here: